Company Filing History:
1 out of 39 
1 out of 1 Years Active: 2025
Title: Claudia Tregnago: Innovator in Cancer Treatment
Introduction
Claudia Tregnago is a notable inventor based in Albignasego, Italy. She has made significant contributions to the field of medicine, particularly in cancer treatment. Her innovative work focuses on developing novel compounds that can aid in the fight against pediatric acute myeloid leukemia.
Latest Patents
Claudia Tregnago holds a patent for "Thioridazine derivatives and their use for the treatment of cancer." This invention relates to novel thioridazine analogue compounds, particularly suitable for treating pediatric acute myeloid leukemia harboring the t(6;11)(q27;q23) KMT2A/AFDN rearrangement. She has 1 patent to her name, showcasing her dedication to advancing medical science.
Career Highlights
Throughout her career, Claudia has worked with esteemed institutions such as the University of Padua and the Pediatric Research Institute Città Della Speranza. Her work in these organizations has allowed her to collaborate with other professionals in the field, enhancing her research and innovation capabilities.
Collaborations
Claudia has collaborated with notable colleagues, including Martina Pigazzi and Romeo Romagnoli. These partnerships have contributed to her success and the advancement of her research in cancer treatment.
Conclusion
Claudia Tregnago is a pioneering inventor whose work in developing thioridazine derivatives represents a significant step forward in cancer treatment. Her contributions to medical research are invaluable, and her innovative spirit continues to inspire others in the field.